Connect with us

International

New York: Court reduces number of licenses awarded to dispensaries

Published

em

Listen to this article

More than 30 dispensary license holders, who were given the green light in August to move forward with their retail businesses, saw the situation reverse last week following an injunction issued by the Supreme Court of Albany County. This legal outage has left 410 successful retailer applicants at a loss for what to do, with their hopes of progress stalled. 

legal conflicts

The road to allowing access to cannabis for adult use in New York has been anything but fast. This slowdown of an already sluggish program is the result of a lawsuit filed on August 2 by four disabled veterans. Their argument is that the New York Office of Cannabis Management (OCM) violated the Cannabis Taxation and Regulation Act (MRTA) by excluding them and other groups from licensing opportunities.

Just five days after the filing of the lawsuit, on August 7, New York State Supreme Court Justice Kevin Bryant issued a preliminary injunction. This injunction prevented OCM regulators from granting additional licenses or approving the opening of dispensaries to those struggling to establish their businesses.

Implications for Adult Conditional Use Dispensary (CAURD) license holders

The preliminary injunction has had a significant impact on the 463 conditional adult-use retail dispensary licenses (CAURD) awarded to social equity applicants since the end of 2022. Of these licenses, 23 have already started operations, including 18 dispensaries and five operators of distribution. These 23 companies are committed to combating the illicit market and satisfying the demand for legal cannabis in a state with a population of around 19,5 million inhabitants.

Injunction Exceptions: A Glimmer of Hope

Following an initial hearing, Judge Bryant introduced, on 18 August, an exception to the temporary restraining order for CAURD awardees: companies that could demonstrate significant economic losses for their investments and that had fulfilled all the prerequisites of licensing. This included approval of the local plan by the MCO Cannabis Control Board and, if applicable, local municipalities prior to the August 7th injunction.

Judge Bryant highlighted that the court had established a process by which individual license holders could prove that they should be exempt from the injunction based on their unique circumstances.

Reduction in affected license holders

On 22 August, the court released a list of 30 CAURD license holders who met the exemption criteria. As a result, the number of licensees affected by the preliminary order was reduced from 440 to 410. While relief was granted to 30 prospective cannabis companies, the fate of the remaining 410 companies remains uncertain as litigation continues.

The plaintiffs' argument is based on the Cannabis Regulation and Taxation Act (MRTA), which stipulates that the CMO's Cannabis Control Board must open the initial adult-use cannabis retail dispensary license application period. simultaneously for all applicants.

Judge Bryant recognized the persuasive authority supporting the plaintiffs' claim that the OCM failed to respect the plain language of the relevant legislation.

Precedents and Impacts on the New York Cannabis Market

This isn't the first lawsuit to disrupt the launch of adult-use cannabis in New York. Another lawsuit filed in September 2022 by Variscite NY One Inc. resulted in an injunction affecting retail cannabis licenses in specific regions.

Judge Bryant criticized the OCM for advancing the CAURD program despite ongoing litigation and awareness of constitutional concerns. He pointed out that the defendants' actions may have contributed to the harm they now present in their case.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Events1 hours ago

CB Expo returns to Dortmund, Germany, with Intertabac from 19 to 21 September

The Cannabis Business Expo and Conference (CB Expo), hosted by Ben Arn, takes place from September 19-21, XNUMX.

Opinion1 hours ago

Australia: The meteoric rise of the medicinal cannabis market

Since 2021, Australia’s market growth has outpaced established markets such as Canada and Germany. The new data...

International1 hours ago

UK: Study finds CBD does not mitigate adverse effects of THC on brain connectivity and may even intensify them

Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are two of the most researched compounds in cannabis, often studied for their different...

Hemp3 days ago

Italian court suspends ban on CBD oils, but hemp sector protests continue across the country

Italy's embattled hemp industry demonstrated in unison yesterday to protest against the attempted...

Hemp4 days ago

Italy: Hemp Industry Fights Government Crackdown on CBD and Hemp-Derived Cannabinoids

Italy's hemp industry is facing its biggest challenge yet as the government introduces measures...

International4 days ago

Pakistan wants a regulated cannabis industry, but with a 0,3% THC limit

Pakistan is set to establish its own medicinal cannabis industry, with the National Assembly set to vote...

International1 weeks ago

Volkswagen invests in industrial hemp leather for car interiors

After brands such as Ford, BMW or Mercedes, Volkswagen has started a cooperation with the German start-up Revoltech GmbH...

International1 weeks ago

Jazz Pharmaceuticals fails Phase 3 Epidyolex clinical trial in Japan

Pharmaceutical giant Jazz recently announced that its leading cannabinoid treatment, Epidyolex, failed clinical trials...

Press Releases1 weeks ago

UK: Landlords risk breaching Equality Act over prescribed cannabis

Landlords, property managers and housing associations are currently at risk of breaching the Equality Act due to...

International1 weeks ago

USA: New York destroys four tons of cannabis products worth $63 million

City officials in New York City have incinerated more than four tons of unregulated cannabis products...